Meningitis PHCL 442 Lab Discussion Jamilah Al-Saidan M.Sc.

Slides:



Advertisements
Similar presentations
Karen Broder, M.D. Epidemic Intelligence Service Officer
Advertisements

Risk of invasive H. influenzae disease in patients with chronic renal failure: a call for vaccination? M. Ulanova, S. Gravelle, N. Hawdon, S. Malik, D.
Liza Chapman, Pharm.D. GPhA Annual Meeting
Meningococcemia: Epidemiology & Prevention Baylor College of Medicine Med-Peds Continuity Clinic Anoop Agrawal, M.D.
Update on Pneumococcal Vaccines
Haemophilus influenzae type B and Hib Vaccine Dr Seyed Mohsen Zahraei Center for Communicable Disease Control.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
Copyright © 2004 Pearson Education, Inc., publishing as Benjamin Cummings PowerPoint ® Lecture Slide Presentation prepared by Christine L. Case Microbiology.
Haemophilus influenzae type b
Meningitis Created By: VSU Student Health Center Nursing Staff.
Flu and Pneumo (Vaxigrip and Pneumo23)
Meningitis.
Ten Leading Causes of Death. Name the 10 leading causes of death and rank them in order from greatest to least. Name the 10 leading causes of death and.
1 1 Immunization Update 2011 Connecticut Immunization Teleconference April 19, 2011 William Atkinson, MD, MPH National Center for Immunization and Respiratory.
Developed By: Barbara (Bobbi) P. Clarke, PhD. RD Professor & Extension Health Specialist, Co-Director for The University of Tennessee Center for Community.
Splenectomy Vaccine Protocol PIDPIC Rationale Spleen clears encapsulated bacteria and infected erythrocytes Serves as one of the largest lymphoid.
TM Prepared for your next patient. Review of Selected Changes to the 2012 Immunization Schedules H. Cody Meissner, MD Floating Hospital for Children Tufts.
IMMUNIZATION (1) “ Discuss the population health benefits of immunization programs ” Probability of contracting communicable disease depends on probability.
Pneumococcal vaccine Polyvalent Untoward reaction in older children and adult Responsiveness is unpredictable in children younger than 2 23-valent pneumococcal.
Julio A. Ramirez, MD, FACP Professor of Medicine Chief, Infectious Diseases University of Louisville Chief, Infectious Diseases Veterans Affairs Medical.
Bacterial Meningitis By Dana Burkart.
Meningitis. What is Meningitis? Inflammation of the tissues that cover the brain and spinal cord Organisms such as bacteria or viruses can infect the.
Haemophilus influenzae type B and Hib Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
 Meningitis is a serious inflammation of the meninges, the thin, membranous covering of the brain and the spinal cord. Two types:  Viral; flu like.
30th anniversary of starting EPI
Central Nervous System Infections. RABIES.
Streptococcus pneumoniae Lecture 9 Summer, 2004 Demosthenes Pappagianis, MD MMI 480B.
Immunization Schedule for Filipino children. Objectives To present the 2013 Immunization schedule for Filipino children with focus on –Minimum age for.
Chris Knefelkamp, PharmD PGY2 Internal Medicine Resident Richard L. Roudebush VA Medical Center September 17, 2015 A SHOT IN THE DARK: PNEUMOCOCCAL PNEUMONIA.
Adult Immunization 2010 Pneumococcal Segment This material is in the public domain This information is valid as of May 25, 2010.
MENINGOCOCCAL PNEUMOCOCCAL TETANUS, DIPHTHERIA, PERTUSSIS VARICELLA HEPATITIS A HEPATITIS B HUMAN PAPILLOMA VIRUS Anyone starting at 6 mos old y/o.
Streptococcus pneumoniae pneumococus PneumoniaMeningitisbacteraemia.
Microbiology of Acute Pyogenic Meningitis
Infections of the Central Nervous System. Definitions Meningitis Encephalitis. meningoencrphaLITIS.
TM Prepared for your next patient. Discussion of Changes to the 2013 Immunization Schedules H. Cody Meissner, MD Floating Hospital for Children Tufts University.
Visibility of Vaccination and How Do We Improve?
Bacterial Meningitis Brie Noble.
BCG Vaccine Usual reactions induration: 2 – 4 wks pustule formation: 5 – 7 wks scar formation: 2 – 3 months Accelerated Reactions: induration: 2-3 days.
CNS block Prof.Hanan Habib. Definition Pyogenic meningitis is an inflammation of the meninges affecting Pia, Arachnoid and subarachnoid space. A serious.
MENINGOCOCCAL POLYSACCHARIDE PNEUMOCOCCAL POLYSACCHARIDE TETANUS, DIPHTHERIA, PERTUSSIS VARICELLA HEPATITIS A HEPATITIS B HUMAN PAPILLOMA VIRUS Anyone.
Meningococcal Disease and Meningococcal Vaccines
Big and Small Changes in Vaccines July 31, Melissa Martinez MD FAAFP Professor Division of General Internal Medicine No Conflicts of Interest to.
Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at
Streptococcus pneumoniae pneumococus PneumoniaMeningitisbacteraemia.
 Thomas F. Koinis, MD, FAAFP  Duke Primary Care Oxford  February 9, 2016.
Date of download: 5/27/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. CDC adult immunization based on vaccine and indications. Notes:
Date of download: 5/27/2016 From: Recommended Adult Immunization Schedule: United States, 2009(1) Ann Intern Med. 2009;150(1): doi: /
What is a vaccine? A vaccine is a medicine that's given to help prevent a disease. Vaccines help the body produce antibodies. These antibodies protect.
September 16, 2014 Bedford Senior Center Joyce Cheng RN Community Health Nurse Bedford Board of Health.
 Carolyn A. Parry, MPH CDC Public Health Advisor Montana Immunization Program 2016 Regional Immunization Workshops.
Haemophilus influenzae type B and Hib Vaccine
Date of download: 6/21/2016 From: Recommended Adult Immunization Schedule: United States, October 2007–September 2008(1) Ann Intern Med. 2007;147(10):
Date of download: 6/22/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Notes: aHepatitis B vaccine (HepB). AT BIRTH: All newborns should.
Chapter 28 Meningococcal Disease. Epidemiology – U.S. Each year 1,400-3,000 cases of meningococcal disease (MD) in the US per 100,000 population.
Assist Prof Dr. Syed Yousaf Kazmi
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory.
Welcome To Presentation w Subject :Pharmaceutical Microbiology -1 w Topic: Pneumonia
Adult Immunizations August 23, 2004 Vinod Kurup, MD
Guidelines for Vaccinating Dialysis Patients BY: DR. JONAIDI ASSOCIATE PROF. OF INFECTIOUS DISEASES.
Date of download: 9/17/2016 From: Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United.
Pneumococcal Vaccination Tool
Pneumococcal Vaccination Small group cases:Facilitator’s Guide
Pneumococcal vaccination in adults: PCV13?.. PPSV23?.. both??
© I.M.Quizitor Pediatrics Date.
BACTERIAL MENINGITIS IN ADULTS
PROF.HANAN HABIB DEPARTMENT OF PATHOLOGY,COLLEGE OF MEDICINE KSU
Pathophysiology of Febrile Neutropenia
Ontario’s Pneumococcal Vaccination Program Allison McGeer
Meningitis Created By: VSU Student Health Center Nursing Staff
Presentation transcript:

Meningitis PHCL 442 Lab Discussion Jamilah Al-Saidan M.Sc

Topics we will cover in Meningitis Microbiology of bacterial meningitis Prevention of H. influenzae type b meningitis Prevention of N. meningitidis meningitis Prevention of S. pneumoniae meningitis

Microbiology The bacterial etiologies of meningitis correlate very well with age and underlying conditions. Q: For each age group or predisposing condition, what is the most likely causative organism of meningitis? Assignments: Word processing Reference (s) Answered by

Microbiology GroupMost likely organism ≤ 1 monthS.agalactiae, E.coli, L.monocytogenes, Klebsiella 1–23 monthsS.pneumoniae, N.meningitidis, S. agalactiae, H.influenzae, E. coli 2-50 yearsN.meningitidis, S.pneumoniae ≥ 50 yearsS.pneumoniae, N.meningitidis, L.monocytogenes, aerobic gram-negative bacilli Head traumaS. pneumoniae, H. influenzae, group A b-hemolytic streptococci Post- neurosurgery Gram - bacilli (P.aeruginosa), S.aureus, coagulase- negative staphy. (S.epidermidis)

Prevention of H. influenzae type b Meningitis Anyone > 2 mo should be vaccinated HbOC, PRPT, and PRP-OMP are equally effective Side effects: fever, redness & swelling at site of infection in only < 4% of patients

Prevention of H. influenzae type b Meningitis Schedule Vaccine2 mo4 mo6 mo12 mo15 mo HbOCDose 1Dose 2Dose 3--Booster PRP-TDose 1Dose 2Dose 3--Booster PRP-OMPDose 1Dose 2Booster--

Prevention of N. meningitidis Meningitis N. meningitidis is responsible for outbreaks & epidemics Type A, B & C are responsible for > 90% of N. meningitidis infections Vaccine not cover B Level of antibodies achieved in 7 – 10 days

Prevention of N. meningitidis Meningitis Vaccination not recommended for general population Who should be vaccinated? 1.Patients with underlying complement deficiency 2.Anatomical/functional asplenia 3.Patients traveling to endemic or epidemic areas 4.Areas of outbreaks or epidemic conditions 5.College freshman (living in a dormitory appear to have an increased risk of acquiring meningococci)

Prevention of S. pneumoniae Meningitis 25 serotypes of S. pneumoniae which are responsible for causing 88% of bacterial pneumococcal disease Not given for children < 2 years old Only one single dose is needed But may need to repeat it ≥ 5 years

Prevention of S. pneumoniae Meningitis Who should be vaccinated? 1.Chronic cardiopulmonary disease 2.DM 3.Alcoholism 4.Cirrhosis 5.CSF leak 6.Asplenia 7.Individuals > 65 years old 8.Immunocompromised ( Cancer, CRF, HIV & organ transplant patients DM = Diabetes Mellitus, CRF = Chronic Renal Failure, HIV = Human Immunodeficiency Virus